During the past decade, Gastrointestinal Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gastrointestinal Associates" #1 sponsor was "Medtronic - MITG" with 2 trials, followed by "Abbott" with 1 trials sponsored, "Bausch Health Americas, Inc." with 1 trials sponsored, "Covidien, GI Solutions" with 1 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gastrointestinal Associates" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Gastrointestinal Associates" are "Barrett Esophagus" (2 trials), "Ulcerative Colitis" (2 trials), "Barrett's Esophagus" (1 trials), "Crohn's Disease" (1 trials) and "GERD" (1 trials). Many other conditions were trialed in "Gastrointestinal Associates" in a lesser frequency.

Most popular intervention types in "Gastrointestinal Associates" are "Device" (3 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "5 ASA, enemas, suppositories, corticosteroids" (1 trials), "Ablation System plus anti-secretory medication" (1 trials), "Adalimumab" (1 trials), "Cytosponge™ Cell Collection Device" (1 trials) and "HALO Ablation System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gastrointestinal Associates" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Gastrointestinal Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Gastrointestinal Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gastrointestinal Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".